期刊文献+

抑癌基因BRCA1启动子荧光素酶报告基因的构建及活性测定

Construction and identification of human tumor suppressor gene BRCA1 promotor luciferase report gene vector
下载PDF
导出
摘要 目的:克隆人BRCA1基因的启动子,构建荧光素酶报告基因载体,并在细胞内检其活性,为其后续基因凋控研究提供依据。方法:采用PCR技术,从人正常宫颈组织细胞中扩增出BRCA1启动子,插入荧光素酶报告基因载体pGL3-basic中,测序所扩增的DNA序列,将其转染入HCT116细胞中并检测其活性。结果:酶切及基因测序方法证实所构建质粒含有pGL3-basic全序列及BRCA1启动子上游调控序列,扩增的BRCA1启动子序列正确;双报告基因实验检测荧光素酶活力表明,p53缺失的HCT116细胞中BRCA1启动子明显增加(P<0.05),构建的报告基因具有启动子活性。结论:克隆BRCA1启动子及成功构建人BRCA1启动子报告基因,可实现快速、经济和准确地克隆已知基因启动子分子和构建启动子载体的目的。 Objective To construct the human BRCA1 promotor luciferase report gene vector and detect its activity in cells. Methods The BRCA1 promoter from human normal cervix tissues was amplified by PCR,and was inserted into the luciferase report gene pGL3-basic vector. The amplified DNA sequence was confirmed by sequencing and then the constructed vector was transfected into HCT116 cells to detect its activity by Premaga Dual-luciferase report gene detection system. Results The recombinant plasmid was tested by gel electrophoresis and sequencing analysis,it was proved that the plasmid included pGL3-basic DNA sequence and PRL regulating sequence.The sequencing results indicated that the amplified sequence was correct,in p53 minus HCT116 cells the number of BRCA1 promoter was increased (P0.05),and the luciferase activity detection result demonstrated that the constructed vector had the promotor activity.Conclusion The human BRCA1 promotor luciferase report gene vector has been constructed successfully,and it will become essential material for further study on the function of BRCA1 regulation.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2010年第3期465-468,共4页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(30730046 30721001) 973国家重点基础研究项目资助课题(2002CB513101)
关键词 BRCA1 启动子 荧光素酶 报告基因 BRCA1 promotor luciferase report gene
  • 相关文献

参考文献11

  • 1Yun MH, Hiom K. CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle[J]. Nature, 2009, 459 (7245):460-463.
  • 2Pasche B. Recent advances in breast cancer genetics [J].Cancer Treat Res, 2008, 141 (1): 1-10.
  • 3Sanz DJ, Acedo A, Infante M, et al. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients [J]. Clin Cancer Res, 2010, 16 (6): 1957-1967.
  • 4Mai PL, Chatterjee N, Hartge P, et al. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma [J]. PLoS One, 2009, 4 (3): e4812.
  • 5范德刚,范清宇,张惠中,刘云燕,文艳华.BRCA1基因反义寡核苷酸对人骨肉瘤细胞的影响[J].肿瘤防治研究,2003,30(3):200-202. 被引量:3
  • 6Thakur S, Croce CM. Positive regulation of the BRCA1 promoter[J].J Biol Chem, 1999, 274 (13): 8837-8843.
  • 7Rauch T, Zhong X, Pfeifer GP, et al. 53BP1 is a positive regulator of the BRCA1 promoter [J]. Cell Cycle, 2005, 4 (8): 1078-1083.
  • 8Glait C, Ravid D, Lee SW, et al. Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells[J]. FEBS Lett, 2006, 580 (22): 5268-5274.
  • 9Arizti P, Fang L, Park I, et al. Tumor suppressor p53 is required to modulate BRCA1 expression [J].Mol Cell Biol, 2000, 20 (20): 7450-7459.
  • 10Molli PR, Singh RR, Lee SW, et al. MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene [J]. Oncogene, 2008, 27 (14):1971-1980.

二级参考文献7

  • 1Zheng L, Li S, Boyer TG, et al. Lessons learned from BRCA1 and BRCA2[J]. Oncogene,2000,19(53) :6159-6175.
  • 2Miki Y, Swensen J, Shattuck- Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1[J]. Science, 1994,266(5182) :66-71.
  • 3Wagner RW. Gene inhibition using antisense oligodeoxynucleotides[J]. Nature, 1994,372(6504):333-335.
  • 4Lee CT, Wu S, Gabrilovich D, et al. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines[J]. Cancer Res, 1996,56(13):3038-3041.
  • 5Venkitaraman AR. Functions of BRCA1 and BRCA2 in the biological response to DNA damage[J]. J Cell Sci, 2001,114(Pt 20):3591-3598.
  • 6Somasundaram K, Zhang H, Zheng YX, et al. Arrest of the cell cycle by the tumor suppressor BRCA1 requires the CDK inhibitor P21WAF1/CIP1[J]. Nature, 1997,389(6647):187-190.
  • 7杨彤涛,范清宇,张殿忠,裘秀春,刘树林,马保安,周勇.1株人成骨肉瘤细胞系的建立及特性观察[J].第四军医大学学报,1998,19(3):264-264. 被引量:20

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部